InspireMD (NSPR) Tops Q1 EPS by 28c

InspireMD (NASDAQ: NSPR) reported Q1 EPS of ($0.53), $0.28 better than the analyst estimate of ($0.81). Revenue for the quarter came in at $1.24 million versus the consensus estimate of $2 million.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'
• Deutsche Bank Starts Tandem Diabetes Care (TNDM) at Hold